Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100722234 | 10072223 | 4 | F | 201305 | 20160829 | 20140411 | 20160901 | EXP | PHHY2014BR043420 | NOVARTIS | 84.61 | YR | F | Y | 98.00000 | KG | 20160901 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100722234 | 10072223 | 1 | PS | DIOVAN | VALSARTAN | 1 | Oral | 1 DF, QD (160 MG, IN THE MORNING) (8 YEARS AGO) | 1527291 | 21283 | 1 | DF | TABLET | QD | |||||
| 100722234 | 10072223 | 2 | SS | ATENSINA | CLONIDINE | 1 | Oral | 1 DF, (0.1 UNIT UNSPECIFIED) | 0 | 1 | DF | TABLET | |||||||
| 100722234 | 10072223 | 3 | C | BETAHISTINE HYDROCHLORIDE | BETAHISTINE HYDROCHLORIDE | 1 | Unknown | (12 TO 12 HOURS) | U | 0 | |||||||||
| 100722234 | 10072223 | 4 | C | LABIRIN | BETAHISTINE | 1 | Oral | 1 DF, QD (MANY YEARS AGO) | 0 | 1 | DF | TABLET | QD | ||||||
| 100722234 | 10072223 | 5 | C | EUTHYROX | LEVOTHYROXINE SODIUM | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 100722234 | 10072223 | 6 | C | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 1 DF, QD (10 YEARS AGO) | 0 | 1 | DF | TABLET | QD | ||||||
| 100722234 | 10072223 | 7 | C | RIVOTRIL | CLONAZEPAM | 1 | Oral | 1 DF, QD (10 YEARS AGO) | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100722234 | 10072223 | 1 | Hypertension |
| 100722234 | 10072223 | 2 | Hypertension |
| 100722234 | 10072223 | 3 | Labyrinthitis |
| 100722234 | 10072223 | 4 | Labyrinthitis |
| 100722234 | 10072223 | 5 | Hypothyroidism |
| 100722234 | 10072223 | 6 | Hypertension |
| 100722234 | 10072223 | 7 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100722234 | 10072223 | HO |
| 100722234 | 10072223 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100722234 | 10072223 | Asthenia | |
| 100722234 | 10072223 | Balance disorder | |
| 100722234 | 10072223 | Breast cancer | |
| 100722234 | 10072223 | Deafness unilateral | |
| 100722234 | 10072223 | Dizziness | |
| 100722234 | 10072223 | Limb discomfort | |
| 100722234 | 10072223 | Memory impairment | |
| 100722234 | 10072223 | Movement disorder | |
| 100722234 | 10072223 | Muscle spasms | |
| 100722234 | 10072223 | Muscular weakness | |
| 100722234 | 10072223 | Nervous system disorder | |
| 100722234 | 10072223 | Neuropathy peripheral | |
| 100722234 | 10072223 | Pneumonia | |
| 100722234 | 10072223 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |